While GLP-1 medications like semaglutide have helped thousands manage weight effectively, they are not risk-freeand they're not suitable for everyone
Lilly and Nimbus have been partnering for more than three years on developing a small molecule activator of a specific isoform of AMP-activated protein kinase (AMPK) to treat cardiometabolic diseases, under an up-to-$496 million partnership launched in 2022
Last June at a conference, I was struck by a comment from one of the speakers who talked about the importance of getting away from the current National Sickness Service back to the true ideal of a National Health Service treating patients holistically, focusing on prevention and not just cure, and long-term joint responsibility with the patient for wellness and well-being
Junzhou Chen., Mingdao Mu., Daiwen Chen and Aimin Wu: designed experiments
A 2020 meta-analysis evaluated the effects of NAC on cognitive function in patients with schizophrenia
You can build up your bodys immunity to common diseases and protect your health with the latest vaccines, all ordered by your primary care clinician